The treatment of Vitiligo in VitiligoClinic is based on the “New concept for treatment of vitiligo: Transplantation of noncultured epidermal cell suspension (ncecs) and laser-assisted repigmentation in refractory nonsegmental vitiligo“ led by prof. Kadurina who is based at the Department of Dermatology of University “G.Marconi”, Rome, Italy, under the direction of Prof.Torello Lotti. You will find literature and the full summary of the scientific work of Prof.Kadurina HERE.
The conception includes the latest high point scientific achievements, the latest technologies united united as medical treatment, the application of the newest and most effective light and laser devices and surgery techniques for auto transplantation of melanocytes.
VitiligoCliniC is the first clinic for Vitiligo treatment in Bulgaria. It is led by prof. Kadurina, Full Professor of Dermatology, University “G.Marconi” Rome, Italy, http://csrmr. unimarconi.it/, from 30.08.2015, with consultant - Prof.Torello Lotti and based in:
Address: Sofia 1606, “P.Slaveykov” str. 4 ;
Tel: 02/42 61 073
Mobile: 0884 34 22 46, 0886 19 12 41
Adress: Sofia, “Felix Kanitz” str. 14-16
Tel: 02/951 63 61
Tel./Fax: 02/951 64 57
The offered treatment by VitiligoClinic is consistent with the „Guidelines for the management of vitiligo: the European Dermatology Forum consensus“, published in the British Journal of Dermatology 2012.
This guideline for the treatment of Vitiligo has been developed by the members of the Vitiligo European Task Force /VETF/ and other experts in this field. It summarizes evidence-based and expert-based recommendations.
It will be performed the main techniques for the treatment of vitiligo but the appraisal and the accurate way of application, in order to achieve maximum efficiency, are not the subject of highly specialized medical expertise.
A thorough medical examination is required to assess the type of disease and individualize the appropriate method or a combination of different methods. It is extremely important to consider factors such as patient age, coexisting disease, previous therapy, and others.